» Articles » PMID: 25734076

Quotidian Changes of Genital Tract Cytokines in Human Immunodeficiency Virus-1-infected Women During the Menstrual Cycle

Overview
Date 2015 Mar 4
PMID 25734076
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The role of hormonal changes throughout the menstrual cycle on genital tract inflammation during chronic human immunodeficiency virus (HIV) infection is not well defined, but it has implications for HIV prevention. We assessed daily levels of 26 vaginal cytokines and chemokines from 15 women infected with HIV-1. Taking into account coexisting sexually transmitted infections, behavioral factors, and menstruation, this study illustrates cyclic patterns of granulocyte macrophage colony-stimulating factor, interferon-α2, interleukin (IL)-6, IL-10, macrophage inflammatory protein (MIP)-1α, MIP-1β, and tumor necrosis factor (TNF)-α. Progesterone was associated with levels of granulocyte colony-stimulating factor, IL-1α, and monocyte chemoattractant protein-1. Interferon-α2, IL-6, MIP-1α, MIP-1β, and TNF-α levels predicted HIV shedding, but these associations were heavily influenced by the menstrual cycle.

Citing Articles

Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.

Hughes S, Levy C, Katz R, Lokken E, Anahtar M, Hall M BMC Med. 2022; 20(1):353.

PMID: 36195867 PMC: 9533580. DOI: 10.1186/s12916-022-02532-9.


The impact of aging on innate and adaptive immunity in the human female genital tract.

Rodriguez-Garcia M, Patel M, Shen Z, Wira C Aging Cell. 2021; 20(5):e13361.

PMID: 33951269 PMC: 8135005. DOI: 10.1111/acel.13361.


Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.

Haddad L, Wall K, Tote K, Kilembe W, Vwailika B, Sharkey T Obstet Gynecol. 2019; 134(3):573-580.

PMID: 31403592 PMC: 9172972. DOI: 10.1097/AOG.0000000000003404.


Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study.

Sharma P, Shahabi K, Spitzer R, Farrugia M, Kaul R, Yudin M PLoS One. 2018; 13(12):e0207266.

PMID: 30513080 PMC: 6279219. DOI: 10.1371/journal.pone.0207266.


Factors Driving the HIV Epidemic in Southern Africa.

McKinnon L, Abdool Karim Q Curr HIV/AIDS Rep. 2016; 13(3):158-69.

PMID: 27137200 DOI: 10.1007/s11904-016-0314-z.

References
1.
Blish C, McClelland R, Richardson B, Jaoko W, Mandaliya K, Baeten J . Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation. J Acquir Immune Defic Syndr. 2012; 61(4):436-40. PMC: 3494808. DOI: 10.1097/QAI.0b013e31826c2edd. View

2.
Hel Z, Stringer E, Mestecky J . Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 2009; 31(1):79-97. PMC: 2852204. DOI: 10.1210/er.2009-0018. View

3.
Al-Harthi L, Kovacs A, Coombs R, Reichelderfer P, Wright D, Cohen M . A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS. 2001; 15(12):1535-43. DOI: 10.1097/00002030-200108170-00011. View

4.
Mukura L, Ghosh M, Fahey J, Cu-Uvin S, Wira C . Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity. AIDS Res Hum Retroviruses. 2012; 28(11):1533-9. PMC: 3484767. DOI: 10.1089/aid.2011.0394. View

5.
Mostad S, Jackson S, Overbaugh J, Reilly M, Chohan B, Mandaliya K . Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis. 1998; 178(4):983-91. DOI: 10.1086/515665. View